Compounds > ammonium hydroxide
Page last updated: 2024-10-16

ammonium hydroxide and Liver Neoplasms

ammonium hydroxide has been researched along with Liver Neoplasms in 71 studies

azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"These findings demonstrated that ADSC-derived exosomes could efficiently alleviate hepatic fibrosis by suppressing HSCs activation and remodeling glutamine and ammonia metabolism mediated by hepatocellular glutamine synthetase, which might be a novel and promising anti-fibrotic therapeutics for hepatic fibrosis disease."8.12ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. ( Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J, 2022)
"Routine use of lactulose to treat mild to moderate hyperammonemia in this patient population was not associated with improved outcomes."8.12Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury. ( Cutler, NS; MacGregor, DA; Sadowski, BW, 2022)
"We aimed to investigate the early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated with lenvatinib."7.91Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy. ( Aikata, H; Chayama, K; Hiramatsu, A; Imamura, M; Kawaoka, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Namba, M; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M, 2019)
" L-Carnitine is a vitamin-like substance and several reports have described the usefulness of L-carnitine supplementation in cases of cirrhosis, with confirmed effectiveness against refractory hepatic encephalopathy."7.81Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma. ( Hasegawa, H; Ishihara, T; Iwasa, M; Kobayashi, Y; Mifuji-Moroka, R; Sekoguchi-Fujikawa, N; Sugimoto, R; Takei, Y; Tanaka, H; Yoshikawa, K, 2015)
"These findings demonstrated that ADSC-derived exosomes could efficiently alleviate hepatic fibrosis by suppressing HSCs activation and remodeling glutamine and ammonia metabolism mediated by hepatocellular glutamine synthetase, which might be a novel and promising anti-fibrotic therapeutics for hepatic fibrosis disease."4.12ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. ( Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J, 2022)
"Routine use of lactulose to treat mild to moderate hyperammonemia in this patient population was not associated with improved outcomes."4.12Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury. ( Cutler, NS; MacGregor, DA; Sadowski, BW, 2022)
"We aimed to investigate the early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated with lenvatinib."3.91Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy. ( Aikata, H; Chayama, K; Hiramatsu, A; Imamura, M; Kawaoka, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Namba, M; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M, 2019)
" L-Carnitine is a vitamin-like substance and several reports have described the usefulness of L-carnitine supplementation in cases of cirrhosis, with confirmed effectiveness against refractory hepatic encephalopathy."3.81Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma. ( Hasegawa, H; Ishihara, T; Iwasa, M; Kobayashi, Y; Mifuji-Moroka, R; Sekoguchi-Fujikawa, N; Sugimoto, R; Takei, Y; Tanaka, H; Yoshikawa, K, 2015)
"Thirteen dogs with hepatic encephalopathy were found to have hyperammonemia and increased retention of plasma sulfobromophthalein."3.65Hyperammonemia and hepatic encephalopathy in the dog. ( Kaneko, JJ; Strombeck, KR; Weiser, MG, 1975)
"Fibrolamellar hepatocellular carcinoma is a rare type of hepatocellular carcinoma with unclear etiology."2.82Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review. ( Ahmed, A; Ata, F; Gaber, M; Hashim, A; Mahfouz, A; Musa, S; Petkar, M; Schirmacher, P, 2022)
"Mycophenolic acid was detected in all cats."2.61 ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019)
"Hyperammonemic encephalopathy is a recurrent problem in these patients, and established treatments based on the assumption of liver failure are unsuccessful."1.91Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. ( Alwaseem, H; Clark, J; Coffino, P; Heissel, S; Knox, J; Lahasky, R; Levin, SN; Lyons, B; Migler, RD; Molina, H; Requena, D; Shebl, B; Shirani, M; Simon, SM; Surjan, R; Tomasini, MD; Torbenson, MS, 2023)
"Patients who developed encephalopathy had higher median ammonia levels, but there was no association between the severity of hyperammonemia and liver tumor burden or presence of liver insufficiency."1.72Prognostic significance of hyperammonemia in neuroendocrine neoplasm patients with liver metastases. ( Brabander, T; Charehbili, A; de Herder, WW; den Hoed, CM; Feelders, RA; Hofland, J; Langendonk, J; Refardt, J; Zandee, WT, 2022)
"Hyperammonemic encephalopathy (HAE) is a serious paraneoplastic syndrome, and several cases of HAE have been reported in patients with FLHCC."1.62Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers. ( Han, N; Jin, HY; Kim, SH; Ko, JM; Lee, JA; Lee, JS; Park, BK; Park, HJ; Park, M, 2021)
"Conclusion Rifaximin administration for hepatic encephalopathy improved the CONUT and ALBI scores."1.56Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy. ( Azumi, M; Endo, S; Honma, T; Imai, M; Ishikawa, T; Iwanaga, A; Nozawa, Y; Sano, T; Yoshida, T, 2020)
"Minimal hepatic encephalopathy is associated with an increased risk of mortality in patients with liver cirrhosis, independent of hepatocellular carcinoma stage or Child-Pugh score."1.51Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis. ( Hanai, T; Imai, K; Moriwaki, H; Shimizu, M; Shiraki, M; Suetsugu, A; Takai, K; Watanabe, S, 2019)
" The meals differed in the bioavailability of the label."1.31Differences detected in vivo between samples of aflatoxin-contaminated peanut meal, following decontamination by two ammonia-based processes. ( Carthew, P; Coker, RD; Hoogenboom, LA; Judah, DJ; Latour, I; Nagler, MJ; Neal, GE; Verma, A; Weir, L, 2001)
"To resolve this issue, we used human hepatoma cell lines (Hep G2, Huh 7) in a type I collagen-coated monolayer culture system, and analyzed liver specific functions such as ammonia removal and albumin synthesis capacity."1.31[Basic study about the development of the hybrid-artificial liver support system using human hepatoma cell lines (Hep G2, Huh 7): effects on liver functions by extracellular matrix (type I collagen) in monolayer culture]. ( Fujii, M; Funatsu, K; Ijima, H; Nakazawa, K; Shirabe, K; Sugimachi, K; Yamashita, Y, 2001)
"It is well known that cases with multiple myeloma reveal various clinical manifestations such as pancytopenia, hyperproteinemia, renal dysfunction, bone lesions, hypercalcemia and immunodeficiency."1.30In vitro excess ammonia production in human myeloma cell lines. ( Hata, H; Ichiki, T; Kouguchi, K; Otsuki, T; Sakaguchi, H; Ueki, A; Wada, H; Yamada, O; Yawata, Y, 1998)
"In horses with hepatic necrosis, lipidosis, neoplasia and cirrhosis, progression of the disease was studied by serial measurements of total serum bile acid concentrations and of plasma glutamate dehydrogenase (GD) and gamma glutamyl transferase (gamma GT) and by liver biopsy."1.29Clinical and pathological studies in horses with hepatic disease. ( West, HJ, 1996)
"Orotic acid feeding was also associated with the tendency for development of larger mammary tumors induced by chemical carcinogens in rats and with development of urinary bladder calculi containing high concentrations of orotic acid in mice."1.28Nitrogen-stimulated orotic acid synthesis and nucleotide imbalance. ( Visek, WJ, 1992)
"Sixteen patients with hepatocellular carcinoma (HCC) and seven patients with metastatic liver tumor were studied."1.27Dynamic positron emission tomography with 13N-ammonia in liver tumors. ( Hayashi, N; Konishi, J; Mukai, T; Nagara, T; Saji, H; Shibata, T; Yamamoto, K; Yonekura, Y, 1988)
" From these results, oral administration of polymyxin B is concluded to be useful in the treatment of hyperammonemia and endotoxemia in liver cirrhosis, as a poorly absorbed antibiotic and as an antiendotoxin agent."1.26Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis. ( Adachi, M; Adachi, Y; Enomoto, M; Hashimoto, T; Inoue, H; Nagamine, Y; Nanno, T; Suwa, M; Yamamoto, T, 1982)

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-199028 (39.44)18.7374
1990's6 (8.45)18.2507
2000's12 (16.90)29.6817
2010's12 (16.90)24.3611
2020's13 (18.31)2.80

Authors

AuthorsStudies
Journo, S1
Goldberg, AK1
Sokol, ES1
Zinger, L1
Pasmanik-Chor, M1
Sarvin, B1
Simkin, D1
Fuchs, S1
Shlomi, T1
Wolf, I1
Rubinek, T1
Refardt, J1
den Hoed, CM1
Langendonk, J1
Zandee, WT1
Charehbili, A1
Feelders, RA1
de Herder, WW1
Brabander, T1
Hofland, J1
Ahmed, A1
Ata, F1
Gaber, M1
Petkar, M1
Mahfouz, A1
Schirmacher, P1
Musa, S1
Hashim, A1
Li, G1
He, Y3
Liu, H6
Liu, D1
Chen, L4
Luo, Y2
Qi, L1
Wang, Y18
Zhan, L1
Zhang, N1
Zhu, X2
Song, T2
Guo, H1
Wu, B1
Feng, J3
Guo, J1
Wang, J9
Xiu, G1
Xu, J5
Ning, K1
Ling, B1
Fu, Q1
Dai, W2
Shen, J1
Yan, J1
Bott, AJ1
Maimouni, S1
Daguplo, HQ1
Khayati, K1
Guo, JY1
Zhang, L5
Valvezan, A1
Ding, WX1
Chen, X6
Su, X1
Gao, S2
Zong, WX1
Qutob, HMH1
Saad, RA1
Bali, H1
Osailan, A1
Jaber, J1
Alzahrani, E1
Alyami, J1
Elsayed, H1
Alserihi, R1
Shaikhomar, OA1
Divya, KM1
Savitha, DP1
Krishna, GA1
Dhanya, TM1
Mohanan, PV1
Shah, SF1
Jafry, AT1
Hussain, G1
Kazim, AH1
Ali, M1
Rivani, E1
Endraswari, PD1
Widodo, ADW1
Khalil, MR1
Guldberg, R1
Nørgård, BM1
Uldbjerg, N1
Wehberg, S1
Fowobaje, KR1
Mashood, LO1
Ekholuenetale, M1
Ibidoja, OJ1
Romagnoli, A1
D'Agostino, M1
Pavoni, E1
Ardiccioni, C1
Motta, S1
Crippa, P1
Biagetti, G1
Notarstefano, V1
Rexha, J1
Perta, N1
Barocci, S1
Costabile, BK1
Colasurdo, G1
Caucci, S1
Mencarelli, D1
Turchetti, C1
Farina, M1
Pierantoni, L1
La Teana, A1
Al Hadi, R1
Cicconardi, F1
Chinappi, M1
Trucchi, E1
Mancia, F1
Menzo, S1
Morozzo Della Rocca, B1
D'Annessa, I1
Di Marino, D1
Choya, A1
de Rivas, B1
Gutiérrez-Ortiz, JI1
López-Fonseca, R1
Xu, S1
Cheng, B1
Huang, Z3
Liu, T3
Li, Y9
Jiang, L1
Guo, W2
Xiong, J1
Amirazodi, M1
Daryanoosh, F1
Mehrabi, A1
Gaeini, A1
Koushkie Jahromi, M1
Salesi, M1
Zarifkar, AH1
Studeny, P1
Netukova, M1
Nemcokova, M1
Klimesova, YM1
Krizova, D1
Kang, H1
Tao, Y1
Zhang, Q6
Sha, D1
Chen, Y1
Yao, J1
Gao, Y2
Liu, J7
Ji, L1
Shi, P1
Shi, C1
Wu, YL1
Wright, AI1
M El-Metwaly, N1
A Katouah, H1
El-Desouky, MG1
El-Bindary, AA1
El-Bindary, MA1
Kostakis, ID1
Raptis, DA1
Davidson, BR1
Iype, S1
Nasralla, D1
Imber, C1
Sharma, D1
Pissanou, T1
Pollok, JM1
Hughes, AM1
Sanderson, E1
Morris, T1
Ayorech, Z1
Tesli, M1
Ask, H1
Reichborn-Kjennerud, T1
Andreassen, OA1
Magnus, P1
Helgeland, Ø1
Johansson, S1
Njølstad, P1
Davey Smith, G1
Havdahl, A1
Howe, LD1
Davies, NM1
Amrillah, T1
Prasetio, A1
Supandi, AR1
Sidiq, DH1
Putra, FS1
Nugroho, MA1
Salsabilla, Z1
Azmi, R1
Grammatikopoulos, P1
Bouloumis, T1
Steinhauer, S1
Mironov, VS2
Bazhenova, TA2
Manakin, YV2
Yagubskii, EB2
Yakushev, IA1
Gilmutdinov, IF1
Simonov, SV1
Lan, K1
Yang, H1
Zheng, J2
Hu, H2
Zhu, T1
Zou, X1
Hu, B2
Olokede, O1
Wu, H1
Holtzapple, M1
Gungor, O1
Kose, M1
Ghaemi, R1
Acker, M1
Stosic, A1
Jacobs, R1
Selvaganapathy, PR1
Ludwig, N1
Yerneni, SS1
Azambuja, JH1
Pietrowska, M1
Widłak, P1
Hinck, CS1
Głuszko, A1
Szczepański, MJ1
Kärmer, T1
Kallinger, I1
Schulz, D1
Bauer, RJ1
Spanier, G1
Spoerl, S1
Meier, JK1
Ettl, T1
Razzo, BM1
Reichert, TE1
Hinck, AP1
Whiteside, TL1
Wei, ZL1
Juan, W1
Tong, D1
Juan, LX1
Sa, LY1
Jie, HFM1
Xiao, G1
Xiang, LG1
Jie, HM1
Xu, C3
Yu, DN1
Yao, ZX1
Bigdeli, F1
Gao, XM1
Cheng, X1
Li, JZ1
Zhang, JW1
Wang, W4
Guan, ZJ1
Bu, Y1
Liu, KG1
Morsali, A1
Das, R1
Paul, R1
Parui, A1
Shrotri, A1
Atzori, C1
Lomachenko, KA1
Singh, AK1
Mondal, J1
Peter, SC1
Florimbio, AR1
Coughlin, LN1
Bauermeister, JA1
Young, SD1
Zimmerman, MA1
Walton, MA1
Bonar, EE1
Demir, D1
Balci, AB1
Kahraman, N1
Sunbul, SA1
Gucu, A1
Seker, IB1
Badem, S1
Yuksel, A1
Ozyazicioglu, AF1
Goncu, MT1
Zhang, H3
Zhou, H2
Deng, Z3
Luo, L2
Ong, SP1
Wang, C4
Xin, H1
Whittingham, MS1
Zhou, G1
Maemura, R1
Wakamatsu, M1
Matsumoto, K1
Sakaguchi, H3
Yoshida, N1
Hama, A1
Yoshida, T2
Miwata, S1
Kitazawa, H1
Narita, K1
Kataoka, S1
Ichikawa, D1
Hamada, M1
Taniguchi, R1
Suzuki, K1
Kawashima, N1
Nishikawa, E1
Narita, A1
Okuno, Y1
Nishio, N1
Kato, K1
Kojima, S1
Morita, K1
Muramatsu, H1
Takahashi, Y1
Yirgu, A1
Mekonnen, Y1
Eyado, A1
Staropoli, A1
Vinale, F1
Zac, J1
Zac, S1
Pérez-Padilla, R1
Remigio-Luna, A1
Guzmán-Boulloud, N1
Gochicoa-Rangel, L1
Guzmán-Valderrábano, C1
Thirión-Romero, I1
Statsenko, ME1
Turkina, SV1
Barantsevich, ER1
Karakulova, YV1
Baranova, NS1
Morzhukhina, MV1
Wang, Q4
Gu, Y1
Chen, C2
Qiao, L2
Pan, F1
Song, C1
Canetto, SS1
Entilli, L1
Cerbo, I1
Cipolletta, S1
Wu, Y4
Zhu, P1
Jiang, Y2
Zhang, X9
Wang, Z4
Xie, B1
Zhang, F1
Luo, A1
Li, S4
Xiong, X2
Han, J3
Peng, X2
Li, M1
Huang, L3
Chen, Q2
Fang, W1
Hou, Y1
Zhu, Y2
Ye, J2
Liu, L1
Islam, MR1
Sanderson, P1
Johansen, MP1
Payne, TE1
Naidu, R1
Cao, J1
Yang, J4
Niu, X1
Liu, X4
Zhai, Y1
Qiang, C1
Niu, Y1
Li, Z5
Dong, N1
Wen, B1
Ouyang, Z1
Zhang, Y10
Li, J14
Zhao, M2
Zhao, J1
Morici, P1
Rizzato, C1
Ghelardi, E1
Rossolini, GM1
Lupetti, A1
Gözüküçük, R1
Cakiroglu, B1
He, X1
Li, R1
Zhao, D3
Ji, X1
Fan, X1
Chen, J3
Zheng, D1
Xie, L1
Sun, S1
Cai, Z1
Liu, Q3
Ma, K1
Sun, X2
Drinkwater, JJ1
Davis, TME1
Turner, AW1
Davis, WA1
Suzuki, Y1
Mizuta, Y1
Mikagi, A1
Misawa-Suzuki, T1
Tsuchido, Y1
Sugaya, T1
Hashimoto, T2
Ema, K1
Hayashita, T1
Levin, SN1
Tomasini, MD1
Knox, J1
Shirani, M1
Shebl, B1
Requena, D1
Clark, J1
Heissel, S1
Alwaseem, H1
Surjan, R1
Lahasky, R1
Molina, H1
Torbenson, MS1
Lyons, B1
Migler, RD1
Coffino, P1
Simon, SM1
Bobenko, AI1
Heller, S1
Schmitt, N1
Cherdtrakulkiat, R1
Lawung, R1
Nabu, S1
Tantimavanich, S1
Sinthupoom, N1
Prachayasittikul, S1
Prachayasittikul, V1
Zhang, B2
Wu, C1
Zhang, Z4
Yan, K1
Li, C4
Li, L7
Zheng, C1
Xiao, Y1
He, D1
Zhao, F1
Su, JF1
Lun, SM1
Hou, YJ1
Duan, LJ1
Wang, NC1
Shen, FF1
Zhang, YW2
Gao, ZW1
Du, XJ1
Zhou, FY1
Yin, Z2
Zhu, J4
Yan, D1
Lou, H1
Yu, H2
Feng, C1
Hu, X1
Shen, Y2
Hu, D2
Chen, H1
Wu, X3
Duan, Y1
Zhi, D1
Zou, M2
Zhao, Z1
Yang, X3
Zhang, J5
Wang, H4
Popović, KJ1
Popović, DJ1
Miljković, D1
Lalošević, D1
Čapo, I1
Popović, JK1
Liu, M4
Song, H2
Xing, Z1
Lu, G1
Chen, D6
Valentini, AM1
Di Pinto, F1
Coletta, S1
Guerra, V1
Armentano, R1
Caruso, ML1
Gong, J1
Wang, N1
Bian, L1
Wang, M1
Ye, M1
Wen, N1
Fu, M1
Fan, W1
Meng, Y1
Dong, G1
Lin, XH1
Liu, HH1
Gao, DM1
Cui, JF1
Ren, ZG1
Chen, RX1
Önal, B1
Özen, D1
Demir, B1
Akkan, AG1
Özyazgan, S1
Payette, G1
Geoffroy, V1
Martineau, C1
Villemur, R1
Jameel, T1
Baig, M1
Gazzaz, ZJ1
Tashkandi, JM1
Al Alhareth, NS1
Khan, SA1
Butt, NS1
Geng, Y1
Wang, X7
Basit, A1
Miao, T1
Liu, W2
Jiang, W1
Yu, ZY1
Wu, L2
Qu, B1
Sun, JX1
Cai, AL1
Xie, LM1
Groeneveld, J1
Ho, SL1
Mackensen, A1
Mohtadi, M1
Laepple, T1
Genovesi, S1
Nava, E1
Bartolucci, C1
Severi, S1
Vincenti, A1
Contaldo, G1
Bigatti, G1
Ciurlino, D1
Bertoli, SV1
Slovak, JE1
Hwang, JK1
Rivera, SM1
Villarino, NF1
Cao, G1
Ling, M1
Ji, J1
Sha, Y1
Gao, X1
Liang, C3
Guo, Q2
Zhou, C2
Ma, Z1
Zhao, W3
Xia, X1
Peng, J1
Jia, Z1
Li, F1
Mo, J1
Zhang, S4
Li, X5
Huang, T1
Zhu, Q1
Wang, S1
Ge, RS1
Fortunato, G1
Lin, J2
Agarwal, PK1
Kohen, A1
Singh, P1
Cheatum, CM1
Zhu, D1
Hayman, A1
Kebede, B1
Stewart, I1
Chen, G1
Frew, R1
Guo, X1
Gong, Q1
Borowiec, J1
Han, S2
Zhang, M2
Willis, M1
Kreouzis, T1
Yu, K1
Chirvony, VS1
Sekerbayev, KS1
Pérez-Del-Rey, D1
Martínez-Pastor, JP1
Palazon, F1
Boix, PP1
Taurbayev, TI1
Sessolo, M1
Bolink, HJ1
Lu, M3
Lan, Y1
Xiao, J1
Song, M2
Huang, Q1
Cao, Y1
Ho, CT1
Qi, B1
Zhang, W2
Fang, L1
Xie, CL1
Chen, R1
Yang, S2
Xia, JM1
Zhang, GY1
Chen, CH1
Yang, XW1
Domenech-Ximenos, B1
Garza, MS1
Prat-González, S1
Sepúlveda-Martínez, Á1
Crispi, F1
Perea, RJ1
Garcia-Alvarez, A1
Sitges, M1
Kalumpha, M1
Guyo, U1
Zinyama, NP1
Vakira, FM1
Nyamunda, BC1
Varga, M1
Drácz, L1
Kolbenheyer, E1
Varga, F1
Patai, ÁV1
Solymosi, N1
Patai, Á1
Kiss, J1
Gaál, V1
Nyul, Z1
Mosdósi, B1
Valdez, M1
Moosavi, L1
Heidari, A1
Novakovic-Agopian, T1
Kornblith, E1
Abrams, G1
McQuaid, JR1
Posecion, L1
Burciaga, J1
D'Esposito, M1
Chen, AJW1
Samy El Gendy, NM1
Wesolowska, P1
Georg, D1
Lechner, W1
Kazantsev, P1
Bokulic, T1
Tedgren, AC1
Adolfsson, E1
Campos, AM1
Alves, VGL1
Suming, L1
Hao, W1
Ekendahl, D1
Koniarova, I1
Bulski, W1
Chelminski, K1
Samper, JLA1
Vinatha, SP1
Rakshit, S1
Siri, S1
Tomsejm, M1
Tenhunen, M1
Povall, J1
Kry, SF1
Followill, DS1
Thwaites, DI1
Izewska, J1
Kang, JH1
Yoon, Y1
Song, J2
Van de Winckel, A1
Gauthier, L1
Chao, CT1
Lee, YH1
Li, CM1
Han, DS1
Huang, JW1
Huang, KC1
Ni, L2
Güttinger, R1
Triana, CA1
Spingler, B1
Baldridge, KK1
Patzke, GR1
Shen, X1
Wang, B5
Xie, S1
Deng, W1
Wu, D1
Voskamp, BJ1
Peelen, MJCS1
Ravelli, ACJ1
van der Lee, R1
Mol, BWJ1
Pajkrt, E1
Ganzevoort, W1
Kazemier, BM1
Tibrewala, R1
Bahroos, E1
Mehrabian, H1
Foreman, SC1
Link, TM1
Pedoia, V1
Majumdar, S1
Jablonski, CL1
Leonard, C1
Salo, P1
Krawetz, RJ1
Yoon, N1
Hong, SN1
Cho, JG1
Jeong, HK1
Lee, KH1
Park, HW1
Barman, S1
Konai, MM1
Samaddar, S1
Haldar, J1
Mohamed, HSH1
Li, CF1
Hu, ZY1
Chen, LH1
Su, BL1
Chu, K1
Liu, YP1
Li, YB1
Zou, Z1
Wu, Z1
Xia, Y2
Zhao, P1
Wang, HT1
de Biase, S1
Pellitteri, G1
Gigli, GL1
Valente, M1
Ohya, K1
Kawaoka, T1
Namba, M1
Uchikawa, S1
Kodama, K1
Morio, K1
Nakahara, T1
Murakami, E1
Hiramatsu, A1
Tsuge, M1
Yamauchi, M1
Imamura, M1
Chayama, K1
Aikata, H1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Hu, K1
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Zang, YP2
Niu, LL2
Fu, YJ3
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Jiang, H1
He, C2
Xiao, Z1
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Zhang, C3
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Zhai, X1
Gilson, E1
Lu, Y1
Yan, R1
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
An, Z1
Jiang, J2
Du, S1
Cui, J1
Wu, W1
Liu, Y7
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Xie, Y2
Tang, J3
Chen, Z3
Luo, W1
Xiong, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Qiu, N1
Yin, J1
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Liu, C2
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Cao, Q1
Yuan, X1
Nie, W1
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Yu, J1
Tian, J1
Hu, J1
Yao, C1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Kawazoe, Y1
Jena, P1
Sun, Z1
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Ruan, Z1
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS2
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Liang, J1
Hu, BC1
Wen, Z1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Shah, PA1
Cho, J1
Albitar, HAH1
Pajot, G1
Ravi, K1
Jin, HY1
Ko, JM1
Kim, SH1
Han, N1
Park, BK1
Park, M1
Park, HJ1
Lee, JA1
Ishikawa, T1
Endo, S1
Imai, M1
Azumi, M1
Nozawa, Y1
Sano, T1
Iwanaga, A1
Honma, T1
Cutler, NS1
Sadowski, BW1
MacGregor, DA1
Solipuram, V1
Baretti, M1
Kim, AY1
Chen, LX1
Fahrner, JA1
Gunay-Aygun, M1
Peng, XP1
Hardenbergh, D1
Ferguson, A1
Griffith, P1
Brancati, M1
Gopalakrishna, H1
Kato, T1
Shubert, C1
Laheru, D1
Yarchoan, M1
Sarkar, J1
Kumari, J1
Tonello, JM1
Kamihira, M1
Kumar, A1
Su, Y1
Yan, L1
Lian, F1
You, J1
Tang, N1
Meng, SS1
Gui, G1
Li, LJ1
Liu, B1
Liang, HX1
Liu, LC1
Huangfu, CS1
Hanai, T1
Shiraki, M1
Watanabe, S1
Imai, K1
Suetsugu, A1
Takai, K1
Moriwaki, H1
Shimizu, M1
Zhang, FY1
Tang, NH2
Wang, XQ2
Li, XJ2
Chen, YL2
Shimada, M3
Morine, Y1
Nagano, H1
Hatano, E1
Kaiho, T1
Miyazaki, M1
Kono, T1
Kamiyama, T1
Morita, S1
Sakamoto, J1
Kusano, M1
Saji, S1
Kanematsu, T1
Kitajima, M1
Iwasa, M1
Sugimoto, R1
Ishihara, T1
Sekoguchi-Fujikawa, N1
Yoshikawa, K1
Mifuji-Moroka, R1
Tanaka, H1
Kobayashi, Y1
Hasegawa, H1
Takei, Y1
Takeshita, S1
Ichikawa, T1
Nakao, K1
Miyaaki, H1
Shibata, H1
Matsuzaki, T1
Muraoka, T1
Honda, T1
Otani, M1
Akiyama, M1
Miuma, S1
Ozawa, E1
Fujimito, M1
Eguchi, K1
Ko, YH1
Verhoeven, HA1
Lee, MJ1
Corbin, DJ1
Vogl, TJ1
Pedersen, PL1
Hashash, JG1
Thudi, K1
Malik, SM1
Yamashita, Y3
Harimoto, N1
Rikimaru, T1
Shirabe, K2
Tanaka, S2
Sugimachi, K3
Ichikawa, A1
Tsuchiya, T1
PEREA, VD1
NELSON, RS1
van Rijn, J1
van den Berg, J1
Schipper, RG1
de Jong, S1
Cuijpers, V1
Verhofstad, AA1
Teerlink, T1
Fukuda, J2
Okamura, K1
Ishihara, K1
Mizumoto, H1
Nakazawa, K3
Ijima, H3
Kajiwara, T1
Funatsu, K3
van de Poll, MC1
Wigmore, SJ1
Redhead, DN1
Beets-Tan, RG1
Garden, OJ1
Greve, JW1
Soeters, PB1
Deutz, NE1
Fearon, KC1
Dejong, CH1
Nagasue, N2
Yukaya, H1
Sasaki, Y1
Ogawa, Y1
Hirose, S1
Adachi, Y1
Enomoto, M1
Adachi, M1
Suwa, M1
Nagamine, Y1
Nanno, T1
Inoue, H2
Yamamoto, T1
Kawada, M1
Nagamori, S1
Aizaki, H1
Fukaya, K1
Niiya, M1
Matsuura, T1
Sujino, H1
Hasumura, S1
Shimizu, K1
Yoshida, H1
Aono, T1
Sakaguchi, T1
Tsukada, K1
Kurosaki, I1
Hatakeyama, K1
West, HJ1
Otsuki, T2
Nakazawa, N1
Taniwaki, M1
Yamada, O2
Wada, H2
Yawata, Y2
Ueki, A2
Ichiki, T1
Kouguchi, K1
Hata, H1
Ito, T1
Siraki, K1
Sugimoto, K1
Sakai, T1
Oomori, S1
Takase, K1
Nakano, T1
Gómez-Lechón, MJ1
Donato, T1
Jover, R1
Rodriguez, C1
Ponsoda, X1
Glaise, D1
Castell, JV1
Guguen-Guillouzo, C1
Neal, GE1
Judah, DJ1
Carthew, P1
Verma, A1
Latour, I1
Weir, L1
Coker, RD1
Nagler, MJ1
Hoogenboom, LA1
Fujii, M1
Tsujita, E1
Sakiyama, R1
Ueda, T1
Visek, WJ2
Clinton, SK1
Truex, CR1
Brekke, OL1
Sinnhuber, RO1
Peplinski, AJ1
Wales, JH1
Putnam, GB1
Lee, DJ1
Ciegler, A1
Erenpreis, IaG1
Zirne, RA1
Strombeck, KR1
Weiser, MG1
Kaneko, JJ1
Nakasaki, H1
Tanaka, Y1
Ohta, M1
Kanemoto, T1
Mitomi, T1
Iwata, Y1
Ozawa, A1
Shibata, T1
Yamamoto, K2
Hayashi, N2
Yonekura, Y2
Nagara, T1
Saji, H2
Mukai, T1
Konishi, J2
Tamaki, N1
Senda, M1
Torizuka, K1
Engelmann, L1
Richardson, UI1
Snodgrass, PJ1
Nuzum, CT1
Tashjian, AH1
Mayfield, ED1
Lyman, K1
Bresnick, E1
Raina, PN1
Rosen, F1
Labadie, P1
Imler, M1
Ruscher, H1
Peter, B1
Kurtz, D1
Stahl, J1
Kovacević, Z1
Morris, HP1
Gips, CH1
Qué, GS1
Szãm, I1
Szentner, J1
Hegedüs-Wein, I1
Vass, A1
Huguet, C1
Bloch, P1
Morisot, P1
Levy, E1
Loygue, J1
Larmi, TK1
Kärkölä, P1
Klintrup, HE1
Heikkinen, E1
Anichkova, SI1
Datiashvili, DS1
Filov, VA1
Kuntz, E1
Michalowicz-Wojczyńska, E1
Summers, RW1
Curtis, SJ1
Hartford, CE1
Rubush, JL1
Nyssen, M1
Dorche, J1
Lechi, C1
Lechi, A1
Lo Cascio, V1

Reviews

5 reviews available for ammonium hydroxide and Liver Neoplasms

ArticleYear
Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
    Current problems in cancer, 2022, Volume: 46, Issue:3

    Topics: Adult; Ammonia; Carcinoma, Hepatocellular; Humans; Lactulose; Liver Neoplasms; Male; Ornithine Carba

2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    Proceedings. Mathematical, physical, and engineering sciences, 2019, Volume: 475, Issue:2227

    Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P

2019
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Nutrition and experimental carcinogenesis.
    The Cornell veterinarian, 1978, Volume: 68, Issue:1

    Topics: Ammonia; Animal Nutritional Physiological Phenomena; Animals; Ascorbic Acid; Colonic Neoplasms; Copp

1978

Trials

5 trials available for ammonium hydroxide and Liver Neoplasms

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).
    International journal of clinical oncology, 2015, Volume: 20, Issue:1

    Topics: Aged; Aged, 80 and over; Ammonia; Asian People; C-Reactive Protein; Female; Gastrointestinal Disease

2015
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Nutrition research (New York, N.Y.), 2009, Volume: 29, Issue:2

    Topics: Aged; Amino Acids, Branched-Chain; Ammonia; Blood Proteins; Carcinoma, Hepatocellular; Chemoemboliza

2009
[Determination of ammonia in the blood for the purpose of diagnosing metastases to the liver].
    Voprosy onkologii, 1969, Volume: 15, Issue:6

    Topics: Ammonia; Clinical Trials as Topic; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neoplasm Met

1969

Other Studies

63 other studies available for ammonium hydroxide and Liver Neoplasms

ArticleYear
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.
    Oncogene, 2022, Volume: 41, Issue:10

    Topics: Adenocarcinoma; Ammonia; Carcinoma, Pancreatic Ductal; Cyclin-Dependent Kinase Inhibitor p15; Cyclin

2022
Prognostic significance of hyperammonemia in neuroendocrine neoplasm patients with liver metastases.
    Endocrine-related cancer, 2022, 03-24, Volume: 29, Issue:5

    Topics: Ammonia; Brain Diseases; Hepatic Insufficiency; Humans; Hyperammonemia; Liver Neoplasms; Neuroendocr

2022
DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism.
    Cell death & disease, 2022, 05-24, Volume: 13, Issue:5

    Topics: Ammonia; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression

2022
ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
    Stem cell research & therapy, 2022, 10-04, Volume: 13, Issue:1

    Topics: Ammonia; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Diethylnitrosamine; Exosomes; Fib

2022
Glutamine synthetase limits β-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1.
    The Journal of clinical investigation, 2022, 12-15, Volume: 132, Issue:24

    Topics: Ammonia; Animals; beta Catenin; Glutamate-Ammonia Ligase; Glutamine; Homeostasis; Liver; Liver Neopl

2022
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma.
    Science advances, 2023, 06-23, Volume: 9, Issue:25

    Topics: Ammonia; Brain Diseases; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neurotoxicity Syndromes

2023
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
    Scientific reports, 2019, 08-20, Volume: 9, Issue:1

    Topics: Aged; Aged, 80 and over; Ammonia; Bilirubin; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver

2019
Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
    The American journal of medicine, 2020, Volume: 133, Issue:12

    Topics: Adult; Ammonia; Brain Diseases; Carcinoma, Hepatocellular; Female; Gastrointestinal Agents; Humans;

2020
Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
    Cancer research and treatment, 2021, Volume: 53, Issue:1

    Topics: Adolescent; Ammonia; Brain Diseases; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Ornit

2021
Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:20

    Topics: Aged; Ammonia; Bilirubin; Body Composition; Carcinoma, Hepatocellular; Female; Hepatic Encephalopath

2020
Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.
    Journal of intensive care medicine, 2022, Volume: 37, Issue:5

    Topics: Adult; Ammonia; Carcinoma, Hepatocellular; Humans; Hyperammonemia; Intensive Care Units; Lactulose;

2022
Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:5

    Topics: Adult; Ammonia; Carcinoma, Hepatocellular; Cytoreduction Surgical Procedures; Hepatic Encephalopathy

2021
Enhanced Hepatic Functions of Genetically Modified Mouse Hepatoma Cells by Spheroid Culture for Drug Toxicity Screening.
    Biotechnology journal, 2017, Volume: 12, Issue:10

    Topics: Acrylamides; Acrylic Resins; Albumins; Ammonia; Animals; Antineoplastic Agents; Carcinoma, Hepatocel

2017
Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells.
    Experimental cell research, 2018, 01-15, Volume: 362, Issue:2

    Topics: Ammonia; Arginase; CCAAT-Enhancer-Binding Proteins; Gene Expression Regulation, Neoplastic; Hep G2 C

2018
[Exposure of human hepatoma cells to nitrite and ammonia promotes invasive activity through activation of ROS/ODC pathway].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:7

    Topics: Ammonia; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Liver Neoplasms; Matrix

2016
Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Carcinoma, Hepatocellular; Female; Hepatic Encephalopa

2019
Simultaneous recovery of dual pathways for ammonia metabolism do not improve further detoxification of ammonia in HepG2 cells.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:5

    Topics: Ammonia; Arginase; Biotransformation; Cell Cycle; Cell Proliferation; Gene Expression Regulation, En

2013
Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Journal of nutritional science and vitaminology, 2015, Volume: 61, Issue:6

    Topics: Ablation Techniques; Aged; Aged, 80 and over; Albumins; Amino Acids, Branched-Chain; Ammonia; Carcin

2015
Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2008, Volume: 7, Issue:6

    Topics: Ammonia; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Gene Expression Regulation, Enz

2008
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
    Journal of bioenergetics and biomembranes, 2012, Volume: 44, Issue:1

    Topics: Adolescent; Ammonia; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Energy Metabolism

2012
An 18-year-old woman with a 15-cm liver mass and an ammonia level of 342.
    Gastroenterology, 2012, Volume: 143, Issue:5

    Topics: Adolescent; Ammonia; Carcinoma, Hepatocellular; Confusion; Female; Humans; Liver Neoplasms; Lung Neo

2012
Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells.
    International journal of cancer, 2003, Feb-20, Volume: 103, Issue:5

    Topics: Albumins; Ammonia; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Differentiation; Cell Divi

2003
A novel function of connexin 32: marked enhancement of liver function in a hepatoma cell line.
    Biochemical and biophysical research communications, 2003, Jul-18, Volume: 307, Issue:1

    Topics: Albumins; Ammonia; Carcinoma, Hepatocellular; Cell Communication; Connexins; Fluorescent Dyes; Gap J

2003
BLOOD AMMONIA LEVELS IN PRIMARY AND METASTATIC CANCER OF THE LIVER.
    Clinica chimica acta; international journal of clinical chemistry, 1964, Volume: 9

    Topics: Adolescent; Ammonia; Blood Chemical Analysis; Dietary Proteins; Geriatrics; Humans; Liver Function T

1964
Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon.
    British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1

    Topics: Ammonia; Arginine; Carcinoma, Hepatocellular; Culture Media; Humans; Hydrogen-Ion Concentration; Hyd

2004
Differentiation effects by the combination of spheroid formation and sodium butyrate treatment in human hepatoblastoma cell line (Hep G2): a possible cell source for hybrid artificial liver.
    Cell transplantation, 2005, Volume: 14, Issue:10

    Topics: Albumins; Ammonia; Animals; Butyrates; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Fema

2005
Effect of major liver resection on hepatic ureagenesis in humans.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 293, Issue:5

    Topics: Adult; Aged; Amino Acids; Ammonia; Blood Flow Velocity; Hepatectomy; Humans; Indocyanine Green; Live

2007
Infusion of branched chain amino acids after partial hepatectomy in man.
    Nutrition and cancer, 1984, Volume: 6, Issue:1

    Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Carcinoma, Hepatocellular; Female; Hepatectomy; H

1984
Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis.
    Gastroenterologia Japonica, 1982, Volume: 17, Issue:6

    Topics: Administration, Oral; Adult; Aged; Ammonia; Carcinoma, Hepatocellular; Endotoxins; Female; Humans; L

1982
[A new liver support system composed of functional human cells and a radial-flow bioreactor].
    Human cell, 1994, Volume: 7, Issue:2

    Topics: Albumins; alpha-Fetoproteins; Ammonia; Artificial Organs; Carcinoma, Hepatocellular; Cells, Cultured

1994
Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:1

    Topics: Alanine Transaminase; Alprostadil; Ammonia; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitro

1996
Clinical and pathological studies in horses with hepatic disease.
    Equine veterinary journal, 1996, Volume: 28, Issue:2

    Topics: Ammonia; Animals; Bile Acids and Salts; Bilirubin; Biopsy; Blood Glucose; Disease Progression; Femal

1996
Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
    International journal of oncology, 1998, Volume: 12, Issue:3

    Topics: Ammonia; Antigens, CD; Carcinoma, Hepatocellular; Cell Culture Techniques; Chromosome Mapping; Chrom

1998
In vitro excess ammonia production in human myeloma cell lines.
    Leukemia, 1998, Volume: 12, Issue:7

    Topics: Ammonia; Culture Media; Humans; Liver Neoplasms; Multiple Myeloma; Polymerase Chain Reaction; Transc

1998
Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
    International journal of oncology, 2000, Volume: 17, Issue:5

    Topics: Adult; Aged; Amino Acids, Branched-Chain; Ammonia; Antineoplastic Combined Chemotherapy Protocols; C

2000
Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2.
    European journal of biochemistry, 2001, Volume: 268, Issue:5

    Topics: Albumins; Ammonia; Biotransformation; Cell Count; Cell Differentiation; Cell Division; Cell Size; Cy

2001
Differences detected in vivo between samples of aflatoxin-contaminated peanut meal, following decontamination by two ammonia-based processes.
    Food additives and contaminants, 2001, Volume: 18, Issue:2

    Topics: Aflatoxins; Ammonia; Animals; Arachis; Biological Availability; Decontamination; Eating; Food Contam

2001
[Basic study about the development of the hybrid-artificial liver support system using human hepatoma cell lines (Hep G2, Huh 7): effects on liver functions by extracellular matrix (type I collagen) in monolayer culture].
    Fukuoka igaku zasshi = Hukuoka acta medica, 2001, Volume: 92, Issue:8

    Topics: Albumins; Ammonia; Carcinoma, Hepatocellular; Collagen Type I; Extracellular Matrix; Humans; Liver;

2001
Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver.
    Cell transplantation, 2001, Volume: 10, Issue:8

    Topics: Albumins; Ammonia; Animals; Cell Culture Techniques; Cell Division; Cells, Cultured; Culture Media;

2001
Aflatoxin in corn: ammonia inactivation and bioassay with rainbow trout.
    Applied and environmental microbiology, 1977, Volume: 34, Issue:1

    Topics: Aflatoxins; Ammonia; Animals; Biological Assay; Carcinoma, Hepatocellular; Diet; Fish Diseases; Food

1977
[Electron-cytochemical method of DNA detection with the aid of ammonia silver].
    Arkhiv patologii, 1979, Volume: 41, Issue:1

    Topics: Ammonia; Animals; Carcinoma 256, Walker; DNA, Neoplasm; Histocytochemistry; Liver Neoplasms; Microsc

1979
Hyperammonemia and hepatic encephalopathy in the dog.
    Journal of the American Veterinary Medical Association, 1975, Jun-01, Volume: 166, Issue:11

    Topics: Alanine Transaminase; Alkaline Phosphatase; Ammonia; Anemia; Animals; Bilirubin; Blood Glucose; Bloo

1975
Nitrogen-stimulated orotic acid synthesis and nucleotide imbalance.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7 Suppl

    Topics: Ammonia; Animals; Carbamyl Phosphate; Cattle; Humans; Liver Neoplasms; Milk; Orotic Acid; Pyrimidine

1992
Congenital absence of the portal vein.
    Annals of surgery, 1989, Volume: 210, Issue:2

    Topics: Adolescent; Ammonia; Bacteria; Feces; Female; Hepatic Veins; Humans; Liver Neoplasms; Mesenteric Vei

1989
Dynamic positron emission tomography with 13N-ammonia in liver tumors.
    European journal of nuclear medicine, 1988, Volume: 14, Issue:12

    Topics: Ammonia; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nitrogen Rad

1988
Imaging of the hepatocellular carcinoma using dynamic positron emission tomography with nitrogen-13 ammonia.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1985, Volume: 26, Issue:3

    Topics: Ammonia; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nitrogen Rad

1985
[Evaluation of blood ammonia level in liver diseases].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1970, Dec-01, Volume: 25, Issue:23

    Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Ammonia; Aspartate Aminotransferases; Bil

1970
Establishment of a clonal strain of hepatoma cells which maintain in culture the five enzymes of the urea cycle.
    Journal of cellular physiology, 1974, Volume: 83, Issue:1

    Topics: Ammonia; Animals; Arginase; Arginine; Bucladesine; Carbamates; Carcinoma, Hepatocellular; Chromosome

1974
Incorporation of bicarbonate-14 C into pyrimidines and into ribonucleic acid of the Novikoff ascites tumor cell.
    Cancer research, 1967, Volume: 27, Issue:3

    Topics: Ammonia; Animals; Aspartic Acid; Bicarbonates; Carcinoma, Hepatocellular; Chromatography, Ion Exchan

1967
Induction of glutamine synthetase by cortisol.
    Biochimica et biophysica acta, 1968, Oct-15, Volume: 165, Issue:3

    Topics: Adrenal Glands; Adrenalectomy; Ammonia; Aniline Compounds; Animals; Azo Compounds; Carcinoma 256, Wa

1968
[Ornithine-carbamoyl-transferase and its clinical valve].
    La Revue du praticien, 1972, Apr-21, Volume: 22, Issue:12

    Topics: Ammonia; Carbon Dioxide; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Hepatitis A; Jaundice; Li

1972
[Action of arginine in a recurrent hepatic coma complicating a feminizing tumor of the adrenal cortex with hepatic metastases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1973, Nov-26, Volume: 49, Issue:48

    Topics: Adolescent; Adrenal Gland Neoplasms; Ammonia; Arginine; Estrogens; Feminization; Hepatic Encephalopa

1973
The role of glutamine in the oxidative metabolism of malignant cells.
    Cancer research, 1972, Volume: 32, Issue:2

    Topics: Ammonia; Animals; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellul

1972
The oral arterial ammonia test in secondary malignancy of the liver and other non-cirrhotic conditions.
    Acta hepato-gastroenterologica, 1974, Volume: 21, Issue:1

    Topics: Administration, Oral; Ammonia; Arteries; Ascites; Cholestasis; Fatty Liver; Hepatitis A; Humans; Hyp

1974
[Effects of arginine malate in experimental and clinical hyperammonemia].
    International journal of clinical pharmacology, therapy and toxicology, 1972, Volume: 6, Issue:3

    Topics: Adult; Aged; Ammonia; Ammonium Chloride; Animals; Arginine; Brain Diseases; Female; Hepatic Encephal

1972
[Major hepatectomy in man. Metabolic consequences].
    La Nouvelle presse medicale, 1972, Volume: 2, Issue:12

    Topics: Adolescent; Adult; Ammonia; Bilirubin; Blood Coagulation Disorders; Blood Coagulation Tests; Blood P

1972
Metabolic changes after hepatic dearterialization in man.
    The Japanese journal of surgery, 1973, Volume: 3, Issue:3

    Topics: Adult; Aged; Ammonia; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Cholesterol; Fatty Acids,

1973
Treatment of patients with hepatic tumors and jaundice by ligation of the hepatic artery.
    Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 108, Issue:2

    Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Ammonia; Aortography; Aspartate Aminotransferases;

1974
[Modern diagnosis of liver function in the chemical laboratory. I. Disturbances of liver cell integrity and metabolic efficiency].
    Munchener medizinische Wochenschrift (1950), 1972, Apr-21, Volume: 114, Issue:16

    Topics: Albumins; Ammonia; Blood Coagulation Factors; Cholestasis; Cholinesterases; Chronic Disease; Diagnos

1972
Blood ammonia in portal hypertension and liver diseases in children.
    Polish medical journal, 1969, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Age Factors; Ammonia; Ammonium Chloride; Chemical and Drug Induced Liver Injury;

1969
Acute hepatic coma treated by cross circulation with irreversibly comatose donor.
    JAMA, 1970, Dec-28, Volume: 214, Issue:13

    Topics: Acute Disease; Adult; Ammonia; Aspartate Aminotransferases; Bilirubin; Blood Donors; Brain Death; Br

1970
[Application of automation to the determination of guanase activity of human serum].
    Clinica chimica acta; international journal of clinical chemistry, 1968, Volume: 22, Issue:3

    Topics: Aminohydrolases; Ammonia; Autoanalysis; Biliary Tract Diseases; Blood Chemical Analysis; Blood Prese

1968
Impaired ammonia metabolism in severe hepatic disease.
    Clinica chimica acta; international journal of clinical chemistry, 1969, Volume: 24, Issue:1

    Topics: Ammonia; Glycine; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Time Factors; U

1969